In GBM cells, YTHDF2 can mediate m6A dependent mRNA decay to inhibit the mRNA and protein expressions of LXRA and HIVEP2 under the activation of EGFR/SRC/ERK signaling. The gene discussed is YTHDF2; the disease is glioblastoma.